The US Food and Drug Administration yesterday launched a website portal it calls a ‘blueprint’ for the full implementation of the Food Safety Modernization Act. The document lays out a plan for actions over the next decade.
After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.
The Center for Science in the Public Interest is urging federal authorities to require testing be done in accredited labs and not just to restrict that to the food importation process. It’s a laudable goal but one that might have unintended consequences,...
Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.
A new publication from the Botanical Adulterants Prevention Program reveals that as many as 90% of the lavender essential oil products on the market can be considered to be adulterated.
An ingredient supplier based in California but with significant operations in Brazil has staked a new claim in the natural vitamin C fray with a new concentrated acerola ingredient.
India’s raw turmeric price this year is about 10% lower than last year partly because COVID-19 lockdowns and market closures have led to a surplus, said a major merchant association in India.
PLT Health in concert with an Indian partner has launched a new boswellia ingredient whose flavor profile and solubility characteristics are claimed to open new doors for this longstanding botanical.
The US Food and Drug Administration says it will move actively to prevent the worldwide trade in dietary ingredients, food ingredients and whole foods from being restricted because of misplaced coronavirus infection concerns.
A contract manufacturer has received a warning letter for manufacturing products containing the stimulant DMHA, which was the subject of a concerted FDA enforcement action in 2019.
COVID-19 has accelerated a number of 'mega' consumer trends and halted others, according to the strategic market insight provider Euromonitor International, providing insight into how consumers' shopping habits are being shaped in the short...
CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.
